GILD

Gilead Sciences, Inc

$126.33

1.55 (1.21%) Today

— up— down

Compare GILD

Market Cap

$158.77B+14.2%

Revenue (TTM)

$29.44B+3.5%

Net Income (TTM)

$9.13B+55.5%

EPS (TTM)

7.35+55.5%

Shares Out

1.24B

P/E Ratio

16.98

Forward P/E

31.07

Dividend

$3.22 (2.56%)

Ex-Dividend Date

Jun 15, 2026

Open

$128.86

Previous Close

$127.88

Day Range

$125.49 – $128.86

52-Week Range

$107.75 – $157.29

Beta

0.36

Volume

6.43M

Avg Volume

6.96M

Analyst Rating

Buy

Exchange

NASDAQ NMS - GLOBAL MARKET

About GILD

Gilead Sciences, Inc. is an American biopharmaceutical company headquartered in Foster City, California, that focuses on researching and developing antiviral drugs used in the treatment of HIV/AIDS, hepatitis B, hepatitis C, influenza, and COVID-19. It also develops medicines in therapeutic areas such as oncology and inflammation and cell therapy.